NME1 and breast carcinoma: Among the trials, several attempts to increase Nm23-H1 and reduce the invasion of metastatic cancer were performed since Nm23-H1 was identified as the first MSP, regulating multiple stages in the metastasis process of breast cancer and melanoma.